TETRACYN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tetracyn, and what generic alternatives are available?
Tetracyn is a drug marketed by Pfipharmecs and Pfizer and is included in four NDAs.
The generic ingredient in TETRACYN is procaine hydrochloride; tetracycline hydrochloride. There are two drug master file entries for this compound. Additional details are available on the procaine hydrochloride; tetracycline hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TETRACYN?
- What are the global sales for TETRACYN?
- What is Average Wholesale Price for TETRACYN?
Summary for TETRACYN
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 66 |
| Patent Applications: | 6,933 |
| DailyMed Link: | TETRACYN at DailyMed |
US Patents and Regulatory Information for TETRACYN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfipharmecs | TETRACYN | tetracycline hydrochloride | CAPSULE;ORAL | 060082-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pfipharmecs | TETRACYN | tetracycline hydrochloride | SUSPENSION;ORAL | 060095-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pfizer | TETRACYN | procaine hydrochloride; tetracycline hydrochloride | INJECTABLE;INJECTION | 060285-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
